Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

WCLC 2025 | Hurdles in assessing radon exposure in lung cancer risk assessment

Marta Garcia de Herreros, MD, Hospital Clinic Barcelona, Barcelona, Spain, comments on the challenges of measuring radon and integrating exposomes in lung cancer risk assessment. Standardized radon measurements are needed, which are currently not as well-established as tobacco smoking, and more research is needed to develop feasible and easy-to-measure methods for radon assessment. This interview took place at 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

The first challenge is how to objectively measure radon and how to standardize radon measurements because it’s not so well standardized as tobacco smoking. So the first thing is to implement radon measurements that are feasible and very easy to measure but we need to standardize. And then once we get the results to integrate all these exposomes combining risk factors, I mean smoking, radon, second-hand smoking, environmental exposures, cancer history, and familial cancer history...

The first challenge is how to objectively measure radon and how to standardize radon measurements because it’s not so well standardized as tobacco smoking. So the first thing is to implement radon measurements that are feasible and very easy to measure but we need to standardize. And then once we get the results to integrate all these exposomes combining risk factors, I mean smoking, radon, second-hand smoking, environmental exposures, cancer history, and familial cancer history. So to integrate the exposome and try to move forward to the clinical implications.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...